Immune System

Mayo Clinic researchers describe a previously unknown type of T cells that can survive harsh cancer therapies. The finding opens doors to studying new immunotherapy approaches for patients who have run out of treatment options.

Mayo Clinic researchers identified a cell-signaling protein that appears to drive pancreatic cancer cell growth that could be a potential therapeutic target.

Researchers identify a protein in immune cells that may play a key role in the development of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.

Mayo Clinic's history of research into giant cell arteritis, an autoimmune disease, has led to recent discoveries that may result in new treatments.

Scientists link macrophages, or the first responders of the immune system, that have become so-called "zombie cells" in early-stage lung tumor growth.

Memory T cells live longer after infection due to an indicator of tissue damage, according to recent research from Mayo Clinic scientists and collaborators. Because ...

For more than twenty-five years, Christopher Evans, Ph.D., a Mayo Clinic orthopedic scientist, has pushed to expand gene therapy beyond its original scope of treating ...

Editor's Note: This is the second of three articles on caloric restriction. The first article focuses on replicating the effects of fasting. The final article ...

Researchers say a patient's routinely assessed immune profile on the first day of hospitalization might provide insights for treating serious cases of COVID-19. A study ...

Where you live may affect whether you receive the cancer-preventing HPV vaccine, suggests a new study published in the journal Vaccine. The first human papillomavirus (HPV) ...